Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ARV-393 |
Trade Name | |
Synonyms | ARV 393|ARV393 |
Drug Descriptions |
ARV-393 is a proteolysis targeting chimera (PROTAC) targeting BCL6, which induces degradation of BCL6 and potentially inhibits tumor growth (Cancer Res (2024) 84 (7_Supplement): ND05) |
DrugClasses | BCL6 Inhibitor 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARV-393 | ARV-393 | 0 | 1 |